Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b.
Fabio Romerio
, Davide Zella
Research output
:
Contribution to journal
›
Article
›
peer-review
61
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Antiviral Agents
9%
Cell Cycle
8%
Cell Cycle Resting Phase
12%
Cell Proliferation
14%
Cyclin D
14%
Cyclin E
13%
Cyclin-Dependent Kinase 2
15%
Cyclin-Dependent Kinase 4
15%
Cytokines
6%
Extracellular Signal-Regulated MAP Kinases
57%
G1 Phase
11%
Growth
5%
Hematologic Neoplasms
10%
Interferon-alpha
42%
Interferon-alpha2b
100%
Interleukin-2
9%
Mitogens
53%
Neoplasms
3%
Phosphotransferases
41%
S Phase
10%
T-Lymphocytes
6%
Chemical Compounds
Additive
35%
EC 2.7.12.2 (Mitogen-Activated Protein Kinase Kinase) Inhibitor
85%
Molecule
18%
Phosphotransferase Inhibitor
67%